News Releases - U.S. Senator Amy Klobuchar

Date	Title
9/9/16	Klobuchar Urges Department of Veterans Affairs to Help Veterans Impacted by ITT Technical Institute Closure
9/8/16	Klobuchar Calls for Senate to Act to Protect Americans From Alarmingly High Cost of Prescription Drugs
9/7/16	Klobuchar, Blumenthal, Gillibrand Urge HHS to Clarify Circumstances of the EpiPen Misclassification, Call for Nationwide Investigation
9/6/16	Klobuchar, Boozman Introduce Bipartisan Legislation to Improve Access to Voluntary Farm Conservation Programs
9/1/16	Klobuchar on the Drug Category Misclassification of Mylan Pharmaceutical’s EpiPen

Date	Title
8/31/16	Klobuchar, Grassley, Blumenthal Call on the Centers for Medicare & Medicaid Services to Provide Information on the Effect of Mylan’s Price Increases on Government Prescription Drug Costs
8/29/16	Klobuchar Statement on Mylan Pharmaceutical’s Launch of a Generic Version of EpiPen
8/25/16	Klobuchar Statement on Mylan Pharmaceutical Announcement to Expand Existing EpiPen Patient Assistance Programs
8/24/16	Klobuchar, Bipartisan Group of Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases
8/22/16	Klobuchar Calls for FTC Investigation of Mylan Pharmaceuticals for Possible Antitrust Violations in Light of Dramatic Price Increase of EpiPen Packs